Michael Gelband’s Biohaven BHVN Stock Holding History

Michael Gelband’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,501,099	Closed	-$12.7M	–	1591
2026 Q1	$12.7M	Buy	1,501,099 +309,073	+26%	+$3.38M	0.1%	183
2025 Q4	$13.5M	Buy	1,192,026 +1,025,168	+614%	+$12.7M	0.11%	181
2025 Q3	$2.5M	Buy	166,858 +123,257	+283%	+$1.79M	0.03%	658
2025 Q2	$615K	Buy	+43,601	New	+$777K	0.01%	1096
2024 Q3	–	Sell	-57,903	Closed	-$2.01M	–	1632
2024 Q2	$2.01M	Buy	+57,903	New	+$2.29M	0.01%	775

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's BHVN Position: Q2 2026 in Review

Michael Gelband sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 1,501,099 shares — an estimated $12.7M sold.

Michael Gelband first reported a position in BHVN in Q2 2024 and held it in 5 quarters. The position peaked at $13.5M in Q4 2025. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Michael Gelband reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 1,501,099 Biohaven shares in Q2 2026, an estimated $12.7M.
Michael Gelband first reported a position in Biohaven in Q2 2024 and held it in 5 quarters.
Michael Gelband's Biohaven position peaked at $13.5M in Q4 2025.
291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.